Upadacitinib sustained-release tablets for the treatment of chronic refractory gouty arthritis: a case report and literature review
BackgroundGouty arthritis (GA) is a crystal-related joint disease caused by the deposition of monosodium urate (MSU) crystals, directly associated with hyperuricemia resulting from purine metabolism disorder and/or reduced uric acid excretion. Acute attacks of typical gouty arthritis are generally r...
Main Authors: | Lishi Yu, Weidong Huang, Honghua Lv, Lie Jin, Wenhui Lei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1357117/full |
Similar Items
-
Do etoricoxib and indometacin have similar effects and safety for gouty arthritis? A meta-analysis of randomized controlled trials
by: Lin TM, et al.
Published: (2018-12-01) -
Plasma adsorption in refractory chronic gouty arthritis flare: A case report
by: Yan Lei, et al.
Published: (2022-11-01) -
Septic arthritis with concomitant gouty arthritis
by: Govind S Shiddapur, et al.
Published: (2015-01-01) -
Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature
by: Sicylle Jeria-Navarro, et al.
Published: (2023-01-01) -
Nimesil treatment of gouty arthritis
by: V G Barskova, et al.
Published: (2003-05-01)